Company registration number 03815444 (England and Wales)
Ross Healthcare Limited
Annual report and financial statements
For the year ended 30 September 2024
Ross Healthcare Limited
Company information
Directors
Mr R W M Pratap
Mr S C Oakes
Mrs A Boxall
Secretary
Mr S C Oakes
Company number
03815444
Registered office
Nova House
2 Hall Farm Way
Smalley
Ilkeston
DE7 6JS
Auditor
DJH Audit Limited
The Glades
Festival Way
Festival Park
Stoke-on-Trent
Staffordshire
ST1 5SQ
Ross Healthcare Limited
Contents
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 7
Statement of income and retained earnings
8
Statement of financial position
9
Notes to the financial statements
10 - 22
Ross Healthcare Limited
Strategic report
For the year ended 30 September 2024
- 1 -

The directors present the strategic report for the year ended 30 September 2024.

Review of the business

The principal activity of the company continued to be that of operating care homes.

 

The directors aim to present a balanced and comprehensive review of the development and performance of their business during the year and its position at the end of the year.  The review is consistent with the size and non-complex nature of the business and is written in the context of the risks and uncertainties they face.

 

The business operates from the following freehold care homes as at the end of the year:-

 

                                                        Registered Beds

Milton Ernest Hall                                              27

Oaktree Court                                                   55

 

The strategy was to continue developing existing care homes through refurbishment and extension programmes. The quality of our homes remains of paramount importance and as at the year end, the homes were recognised as achieving 100% essential standards compliance.

 

The financial performance during the year was in line with directors’ expectations, delivering the benefits of recent capital expenditure and strategic developments. Turnover achieved was £5.47m, generating a gross profit of £2.02m and a net profit before tax of £11k.

 

The business’s key performance indicators communicate the financial performance of the homes and the strength of the Group:-

 

  1. Average fees - The directors are striving to maximise the quality of earnings, through offering high quality environments with highly trained staff teams. The company seeks to generate sustainable income levels to support the cost base of the business, impacted by growing staff costs and utility costs.

     

  2. Occupancy - The occupancy levels continue to remain strong and as at year end was 83.82% of available beds.

     

  3. Gross margin  - A gross margin of 36.99% was generated.

 

The business environment in which the company operates continues to be challenging.  The long-term care market is highly competitive and the company aims to continue to exceed the recommended care standards.

 

The directors are continually assessing risks and uncertainties and are aware that any plans for the future development of the business may be subject to unforeseen future events outside of their control.

 

On behalf of the board

Mr S C Oakes
Director
29 April 2025
Ross Healthcare Limited
Directors' report
For the year ended 30 September 2024
- 2 -

The directors present their annual report and financial statements for the year ended 30 September 2024.

Principal activities

The principal activity of the company continued to be that of providing residential nursing care facilities.

Results and dividends

The results for the year are set out on page 8.

The directors do not recommend payment of an Ordinary dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr R W M Pratap
Mr S C Oakes
Mrs A Boxall
Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Strategic report

The company has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the company's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Ross Healthcare Limited
Directors' report (continued)
For the year ended 30 September 2024
- 3 -
Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

On behalf of the board
Mr S C Oakes
Director
29 April 2025
Ross Healthcare Limited
Independent auditor's report
To the member of Ross Healthcare Limited
- 4 -
Opinion

We have audited the financial statements of Ross Healthcare Limited (the 'company') for the year ended 30 September 2024 which comprise the statement of income and retained earnings, the statement of financial position and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Ross Healthcare Limited
Independent auditor's report (continued)
To the member of Ross Healthcare Limited
- 5 -

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed overleaf.

Ross Healthcare Limited
Independent auditor's report (continued)
To the member of Ross Healthcare Limited
- 6 -

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

 

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

 

 

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

 

 

To address the risk of fraud through management bias and override of controls, we:

 

 

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

 

 

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

 

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Ross Healthcare Limited
Independent auditor's report (continued)
To the member of Ross Healthcare Limited
- 7 -

Use of our report

This report is made solely to the company's member in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's member those matters we are required to state to the member in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's member, for our audit work, for this report, or for the opinions we have formed.

Gary Chadwick FCCA
Senior Statutory Auditor
For and on behalf of DJH Audit Limited
1 May 2025
Accountants
Statutory Auditor
The Glades
Festival Way
Festival Park
Stoke-on-Trent
Staffordshire
ST1 5SQ
Ross Healthcare Limited
Statement of income and retained earnings
For the year ended 30 September 2024
- 8 -
2024
2023
Notes
£
£
Turnover
3
5,473,335
4,679,197
Cost of sales
(3,448,880)
(3,293,071)
Gross profit
2,024,455
1,386,126
Administrative expenses
(1,935,213)
(1,951,713)
Other operating income
11,980
123,699
Operating profit/(loss)
4
101,222
(441,888)
Interest receivable and similar income
7
486,489
676,788
Interest payable and similar expenses
8
(576,880)
(165,061)
Profit before taxation
10,831
69,839
Tax on profit
9
1,394
167,211
Profit for the financial year
12,225
237,050
Retained earnings brought forward
6,575,454
6,338,404
Retained earnings carried forward
6,587,679
6,575,454
Ross Healthcare Limited
Statement of financial position
As at 30 September 2024
- 9 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
11
4,762,778
5,147,222
Current assets
Stocks
12
29,992
29,992
Debtors
13
9,619,384
8,005,703
Cash at bank and in hand
86,330
80,112
9,735,706
8,115,807
Creditors: amounts falling due within one year
14
(5,315,802)
(4,042,946)
Net current assets
4,419,904
4,072,861
Total assets less current liabilities
9,182,682
9,220,083
Creditors: amounts falling due after more than one year
15
(2,424,334)
(2,450,799)
Provisions for liabilities
Deferred tax liability
17
170,569
193,730
(170,569)
(193,730)
Net assets
6,587,779
6,575,554
Capital and reserves
Called up share capital
19
100
100
Profit and loss reserves
20
6,587,679
6,575,454
Total equity
6,587,779
6,575,554

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 29 April 2025 and are signed on its behalf by:
Mr S C Oakes
Director
Company registration number 03815444 (England and Wales)
Ross Healthcare Limited
Notes to the financial statements
For the year ended 30 September 2024
- 10 -
1
Accounting policies
Company information

Ross Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Nova House, 2 Hall Farm Way, Smalley, Ilkeston, DE7 6JS.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Majesticare Holdings 1 Limited. These consolidated financial statements are available from its registered office, Nova House, 2 Hall Farm Way, Smalley, Ilkeston, DE7 6JS.

 

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
1
Accounting policies
(Continued)
- 11 -
1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
45 years straight line on cost
Fixtures, plant and equipment
20% per annum on cost
Computer equipment
33% per annum on cost
Motor vehicles
25% per annum on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets which include cash in hand and deposits held at call with banks.

Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
1
Accounting policies
(Continued)
- 12 -
1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors, cash and bank balances and loans due from related parties, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
1
Accounting policies
(Continued)
- 13 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value though profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
1
Accounting policies
(Continued)
- 14 -
1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.15
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

Government grants relating to turnover are recognised as income over the periods when the related costs are incurred. Grants relating to an asset are recognised in income systematically over the asset's expected useful life. If part of such a grant is deferred it is recognised as deferred income rather than being deducted from the asset's carrying amount.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
- 15 -
3
Turnover and other revenue

An analysis of the company's turnover is as follows:

2024
2023
£
£
Turnover analysed by class of business
Rendering of services
5,473,335
4,679,197
2024
2023
£
£
Other revenue
Interest income
486,489
676,788
Grants received
3,729
3,699
4
Operating profit/(loss)
2024
2023
Operating profit/(loss) for the year is stated after charging/(crediting):
£
£
Government grants
(3,729)
(3,699)
Fees payable to the company's auditor for the audit of the company's financial statements
16,750
16,500
Depreciation of owned tangible fixed assets
273,593
302,984
Profit on disposal of tangible fixed assets
(106,790)
(544,993)
Operating lease charges
24,000
24,000
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Nursing, domestic and other nursing staff
120
109
Head office and operation managers
35
35
Total
155
144
Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
5
Employees
(Continued)
- 16 -

Their aggregate remuneration comprised:

2024
2023
£
£
Wages and salaries
2,693,027
2,978,491
Social security costs
203,232
350,173
Pension costs
60,701
59,265
2,956,960
3,387,929
6
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
-
0
92,017
7
Interest receivable and similar income
2024
2023
£
£
Interest income
Interest receivable from group companies
486,489
676,788
8
Interest payable and similar expenses
2024
2023
£
£
Interest payable to group undertakings
426,924
-
0
Other interest on financial liabilities
149,909
164,957
Interest on finance leases and hire purchase contracts
-
104
Other interest
47
-
0
576,880
165,061
Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
- 17 -
9
Taxation
2024
2023
£
£
Deferred tax
Origination and reversal of timing differences
(1,394)
(167,211)

The actual credit for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Profit before taxation
10,831
69,839
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 25.00%)
2,708
17,460
Tax effect of expenses that are not deductible in determining taxable profit
-
0
930
Tax effect of income not taxable in determining taxable profit
-
0
(136,428)
Depreciation on assets not qualifying for tax allowances
14,720
25,978
Under/(over) provided in prior years
(1,100)
-
0
Deferred tax adjustments in respect of prior years
-
0
(533)
Capital allowances
-
0
1,095
Tax losses utilised
(17,722)
(75,713)
Taxation credit for the year
(1,394)
(167,211)
10
Intangible fixed assets
Goodwill
£
Cost
At 1 October 2023 and 30 September 2024
60,000
Amortisation and impairment
At 1 October 2023 and 30 September 2024
60,000
Carrying amount
At 30 September 2024
-
0
At 30 September 2023
-
0
Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
- 18 -
11
Tangible fixed assets
Freehold land and buildings
Fixtures, plant and equipment
Computer equipment
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 October 2023
6,553,361
3,003,817
-
0
204,268
9,761,446
Additions
-
0
64,345
5,792
-
0
70,137
Disposals
(244,236)
-
0
-
0
-
0
(244,236)
At 30 September 2024
6,309,125
3,068,162
5,792
204,268
9,587,347
Depreciation and impairment
At 1 October 2023
1,766,446
2,709,355
-
0
138,423
4,614,224
Depreciation charged in the year
132,520
113,570
1,600
25,903
273,593
Eliminated in respect of disposals
(63,248)
-
0
-
0
-
0
(63,248)
At 30 September 2024
1,835,718
2,822,925
1,600
164,326
4,824,569
Carrying amount
At 30 September 2024
4,473,407
245,237
4,192
39,942
4,762,778
At 30 September 2023
4,786,915
294,462
-
0
65,845
5,147,222

Land and buildings included non-depreciable assets amounting to £808,352 (2023 - £808,352).

12
Stocks
2024
2023
£
£
Consumables
29,992
29,992
13
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
225,096
295,961
Other debtors
9,172,913
7,455,650
Prepayments and accrued income
167,134
178,084
9,565,143
7,929,695
Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
13
Debtors
(Continued)
- 19 -
2024
2023
Amounts falling due after more than one year:
£
£
Deferred tax asset (note 17)
54,241
76,008
Total debtors
9,619,384
8,005,703
14
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Bank loans
16
113,819
188,762
Trade creditors
86,938
373,655
Taxation and social security
92,068
43,348
Other creditors
4,901,233
3,321,723
Accruals and deferred income
121,744
115,458
5,315,802
4,042,946
15
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Bank loans and overdrafts
16
2,424,334
2,450,799
Amounts included above which fall due after five years are as follows:
Payable by instalments
1,918,846
2,147,747
Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
- 20 -
16
Loans and overdrafts
2024
2023
£
£
Bank loans
2,538,153
2,639,561
Payable within one year
113,819
188,762
Payable after one year
2,424,334
2,450,799

The bank loans and overdraft are secured by a legal charge over Milton Ernest Hall and Oaktree Court.

Loan term debt is in the form of a capital repayment loan with Lloyds Bank Plc, with a variable interest rate of the Bank of England base rate plus 2.56% per annum , maturing in December 2039.

17
Deferred taxation

Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:

Liabilities
Liabilities
Assets
Assets
2024
2023
2024
2023
Balances:
£
£
£
£
Accelerated capital allowances
170,569
193,730
-
76,008
Tax losses
-
-
54,241
-
170,569
193,730
54,241
76,008
2024
Movements in the year:
£
Liability at 1 October 2023
117,722
Credit to profit or loss
(1,394)
Liability at 30 September 2024
116,328
Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
- 21 -
18
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
60,701
59,265

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

19
Share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100

Each class of ordinary shares carry full voting, dividend and capital distribution rights.

20
Profit and loss reserves

The profit and loss reserve represents the retained profits of the company after the payment of any dividends.

21
Financial commitments, guarantees and contingent liabilities

The company has a legal charge and a fixed and floating charge in favour of Lloyds Bank Plc over the freehold properties and assets.

22
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2024
2023
£
£
Within one year
30,000
54,000
Ross Healthcare Limited
Notes to the financial statements (continued)
For the year ended 30 September 2024
- 22 -
23
Related party transactions
Transactions with related parties

The following amounts were outstanding at the reporting end date:

2024
2023
Amounts due to related parties
£
£
Other related parties
4,575,802
3,016,792

The following amounts were outstanding at the reporting end date:

2024
2023
Amounts due from related parties
£
£
Other related parties
7,870,075
7,382,958
Other information

The company is a wholly owned subsidiary of Majesticare Holdings 1 Limited and has taken advantage of the exemption conferred by FRS 102 not to disclose transactions with Majesticare Holdings 1 Limited.

24
Ultimate controlling party

The ultimate parent company is Majesticare Holdings 1 Limited, incorporated in England and Wales.

The ultimate controlling party is Mr R W M Pratap by virtue of his majority shareholding in the parent company.

The largest and smallest group in which the results of the company are consolidated is that headed by Majesticare Holdings 1 Limited, incorporated in England and Wales. The consolidated accounts of this company are available to the public and may be obtained from Companies House, Crown Way, Cardiff, CF14 3UZ. No other group accounts included the results of the company.

2024-09-302023-10-01falseCCH SoftwareCCH Accounts Production 2024.200Mr R W M PratapMr S C OakesMrs A BoxallMr S C Oakesfalsefalse038154442023-10-012024-09-3003815444bus:Director12023-10-012024-09-3003815444bus:Director22023-10-012024-09-3003815444bus:Director32023-10-012024-09-3003815444bus:CompanySecretary12023-10-012024-09-3003815444bus:RegisteredOffice2023-10-012024-09-30038154442024-09-30038154442022-10-012023-09-3003815444core:RetainedEarningsAccumulatedLosses2023-09-3003815444core:RetainedEarningsAccumulatedLosses2022-09-3003815444core:ShareCapital2024-09-3003815444core:ShareCapital2023-09-3003815444core:RetainedEarningsAccumulatedLosses2024-09-3003815444core:RetainedEarningsAccumulatedLosses2023-09-30038154442023-09-3003815444core:LandBuildingscore:OwnedOrFreeholdAssets2024-09-3003815444core:PlantMachinery2024-09-3003815444core:ComputerEquipment2024-09-3003815444core:MotorVehicles2024-09-3003815444core:LandBuildingscore:OwnedOrFreeholdAssets2023-09-3003815444core:PlantMachinery2023-09-3003815444core:ComputerEquipment2023-09-3003815444core:MotorVehicles2023-09-3003815444core:CurrentFinancialInstrumentscore:WithinOneYear2024-09-3003815444core:CurrentFinancialInstrumentscore:WithinOneYear2023-09-3003815444core:Non-currentFinancialInstrumentscore:AfterOneYear2024-09-3003815444core:Non-currentFinancialInstrumentscore:AfterOneYear2023-09-3003815444core:CurrentFinancialInstruments2024-09-3003815444core:CurrentFinancialInstruments2023-09-3003815444core:Goodwill2023-10-012024-09-3003815444core:LandBuildingscore:OwnedOrFreeholdAssets2023-10-012024-09-3003815444core:PlantMachinery2023-10-012024-09-3003815444core:ComputerEquipment2023-10-012024-09-3003815444core:MotorVehicles2023-10-012024-09-300381544412023-10-012024-09-300381544412022-10-012023-09-3003815444core:UKTax2023-10-012024-09-3003815444core:UKTax2022-10-012023-09-300381544422023-10-012024-09-300381544422022-10-012023-09-300381544432023-10-012024-09-300381544432022-10-012023-09-300381544442023-10-012024-09-300381544442022-10-012023-09-3003815444core:Goodwill2023-09-3003815444core:Goodwill2024-09-3003815444core:Goodwill2023-09-3003815444core:LandBuildingscore:OwnedOrFreeholdAssets2023-09-3003815444core:PlantMachinery2023-09-3003815444core:ComputerEquipment2023-09-3003815444core:MotorVehicles2023-09-30038154442023-09-3003815444core:Non-currentFinancialInstruments2024-09-3003815444core:Non-currentFinancialInstruments2023-09-3003815444core:WithinOneYear2024-09-3003815444core:WithinOneYear2023-09-3003815444bus:PrivateLimitedCompanyLtd2023-10-012024-09-3003815444bus:FRS1022023-10-012024-09-3003815444bus:Audited2023-10-012024-09-3003815444bus:FullAccounts2023-10-012024-09-30xbrli:purexbrli:sharesiso4217:GBP